Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1995-2-24
|
pubmed:abstractText |
We investigated the metabolic and hemodynamic effects of a lactate- and a bicarbonate-buffered (bicarbonate concentration 31.4 mmol/l, type I) hemofiltration substitution fluid in a prospective crossover study of 3 weeks each in 11 patients on maintenance hemofiltration. The lactate-buffered hemofiltration (lactate concentration 34-44.5 mmol/l) lead to hyperlactatemia in all patients without signs of overt lactic acidosis but showed a better control of acid-base balance (pH, base excess, standard bicarbonate) than the type I bicarbonate-buffered fluid (p < 0.01). In 6 patients a higher concentration of bicarbonate- (39.7 mmol/l, type II) buffered fluid was tested. The parameters of acid-base balance showed a better control during type II than during type I bicarbonate hemofiltration and were similar to the lactate-buffered phase. Plasma lactate levels between type I and type II bicarbonate hemofiltration were not different. Also in the steady state phase of the treatment (days 7-9 [week 3]) parameters of acid-base balance rose more to normal values during type II than during lactate-buffered hemofiltration. Hemodynamic parameters showed no differences between the three types of buffers used. Furthermore, also the type II bicarbonate fluid was well tolerated. Bicarbonate in a higher concentration (39.7 mmol/l) proved to be a safe and practical alternative to lactate-buffered hemofiltration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bicarbonates,
http://linkedlifedata.com/resource/pubmed/chemical/Buffers,
http://linkedlifedata.com/resource/pubmed/chemical/Hemodialysis Solutions,
http://linkedlifedata.com/resource/pubmed/chemical/Lactates,
http://linkedlifedata.com/resource/pubmed/chemical/Lactic Acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0301-0430
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
257-62
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7834919-Acid-Base Equilibrium,
pubmed-meshheading:7834919-Acidosis,
pubmed-meshheading:7834919-Bicarbonates,
pubmed-meshheading:7834919-Buffers,
pubmed-meshheading:7834919-Cross-Over Studies,
pubmed-meshheading:7834919-Female,
pubmed-meshheading:7834919-Hemodialysis Solutions,
pubmed-meshheading:7834919-Hemofiltration,
pubmed-meshheading:7834919-Humans,
pubmed-meshheading:7834919-Kidney Failure, Chronic,
pubmed-meshheading:7834919-Lactates,
pubmed-meshheading:7834919-Lactic Acid,
pubmed-meshheading:7834919-Male,
pubmed-meshheading:7834919-Middle Aged,
pubmed-meshheading:7834919-Prospective Studies
|
pubmed:year |
1994
|
pubmed:articleTitle |
Which bicarbonate concentration is adequate to lactate-buffered substitution fluids in maintenance hemofiltration?
|
pubmed:affiliation |
II. Medical Clinic, Technical University of Aachen, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|